CellR4 2020; 8: e2846
DOI: 10.32113/cellr4_20205_2846

Editorial – Potential risks of the SARS-related coronavirus 2 infection [COVID-19] in pregnancy

CellR4 2020; 8: e2850
DOI: 10.32113/cellr4_20205_2850

Targeting Toll-Like Receptor 4: a promising strategy to prevent type 1 diabetes occurrence or recurrence

CellR4 2020; 8: e2852
DOI: 10.32113/cellr4_20205_2852

Challenges in managing immunosuppressive therapies for psoriasis during the COVID-19 pandemic

CellR4 2020; 8: e2854
DOI: 10.32113/cellr4_20205_2854

The impact of COVID-19 pandemic on pediatric oncology

CellR4 2020; 8: e2839
DOI: 10.32113/cellr4_20204_2839

Umbilical cord-derived mesenchymal stem cells for COVID-19 patients with acute respiratory distress syndrome (ARDS)

CellR4 2020; 8: e2833
DOI: 10.32113/cellr4_20204_2833

The first clinical case of dry age-related macular degeneration treated with photobiomodulation and nutraceuticals: a protocol proposal

CellR4 2019; 7: e2797
DOI: 10.32113/cellr4_201911_2797

Establishing a national program of islet transplantation in Australia

CellR4 2019; 7: e2786
DOI: 10.32113/cellr4_201911_2786

Islet Transplantation – perspective from Poland

CellR4 2019; 7: e2788
DOI: 10.32113/cellr4_201911_2788

Islet Transplantation in the UK